These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 783095)
21. [Therapy following myocardial infarct]. Hornbostel H; Kaufmann W; Siegenthaler W Dtsch Med Wochenschr; 1971 Dec; 96(50):1952-4. PubMed ID: 5127034 [No Abstract] [Full Text] [Related]
22. Clinical use of digitalis glycosides. An update. Doherty JE Cardiology; 1985; 72(5-6):225-54. PubMed ID: 2866838 [TBL] [Abstract][Full Text] [Related]
23. [Clinical experience with the new cardiac glycoside peruvosid]. Pfund WD Hippokrates; 1969 Aug; 40(16):646-53. PubMed ID: 5810178 [No Abstract] [Full Text] [Related]
24. Effects of digoxin and digitoxin on ventricular function in normal dogs and dogs with heart failure. Hamlin RL; Dutta S; Smith CR Am J Vet Res; 1971 Sep; 32(9):1391-8. PubMed ID: 5094523 [No Abstract] [Full Text] [Related]
25. [Beta-adrenergic receptor blockers in clinical practice]. Czuriga I; Edes I Orv Hetil; 2004 Sep; 145(38):1951-60. PubMed ID: 15535106 [TBL] [Abstract][Full Text] [Related]
26. [Comprehensive indication for glycoside therapy from the neurologic-phychiatric viewpoint]. Diehl LW Ther Ggw; 1975 Mar; 114(3):336, 338-40 342-4 PASSIM. PubMed ID: 1092026 [No Abstract] [Full Text] [Related]
27. [Intestinal absorption of cardiac glycosides in vitro and in vivo]. Forth W; Furukawa E; Rummel W Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 262(1):53-72. PubMed ID: 4237042 [No Abstract] [Full Text] [Related]
28. [Therapy of chronic cardiac insufficiency with cardiac glycosides]. Bonelli J Wien Med Wochenschr; 1982 Oct; 132(19):442-9. PubMed ID: 7179995 [No Abstract] [Full Text] [Related]
29. New information regarding digitalis metabolism. Doherty JE; Hall WH; Murphy ML; Beard OW Chest; 1971 Apr; 59(4):433-7. PubMed ID: 4927990 [No Abstract] [Full Text] [Related]
30. [Determination of the intestinal absorption of cardiac glycosides by measurement of 3H-labelled glycosides in the portal venous blood and in the intestinal lymph of cats]. Forth W; Furukawa E; Rummel W Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(4):406-19. PubMed ID: 4242055 [No Abstract] [Full Text] [Related]
32. [Effects of verapamil on cardiac performance]. Câmpeanu A; Cerin G; Chira R; Pleşa O; Chirilă L Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(1):87-96. PubMed ID: 6145210 [No Abstract] [Full Text] [Related]
33. [Metabolism and intestinal absorption of cardiac glycosides]. Lauterbach F Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1969; 263(1):26-39. PubMed ID: 4896199 [No Abstract] [Full Text] [Related]
34. [Interventricular septum extract in the treatment of some heart diseases]. Scalfi U; Gavina G Minerva Med; 1969 Jun; 60(49):2432-8. PubMed ID: 5802655 [No Abstract] [Full Text] [Related]
35. A guide to the use of propranolol in five cardiac conditions. LeWinter MM Med Times; 1978 Aug; 106(8):44-9. PubMed ID: 150482 [No Abstract] [Full Text] [Related]
36. Use of beta-blockers during and after myocardial infarction. Aronow WS Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097 [TBL] [Abstract][Full Text] [Related]
38. [Present-day cardiac glycoside therapy]. Larbig D Pol Arch Med Wewn; 1976 Dec; 56(6):551-65. PubMed ID: 794849 [No Abstract] [Full Text] [Related]
39. [Current treatment of cardiovascular diseases with special reference to long-term therapy]. Sundermann A Z Arztl Fortbild (Jena); 1967 Jun; 61(12):614-8. PubMed ID: 4969503 [No Abstract] [Full Text] [Related]
40. [The effect of cardiac glycosides on the diastole of the heart]. Storz H Dtsch Med Wochenschr; 1970 Jan; 95(5):224-7. PubMed ID: 5410907 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]